| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Breast-cancer risk in families with mutations in PALB2.
|
N Engl J Med
|
2014
|
4.97
|
|
2
|
Variation of breast cancer risk among BRCA1/2 carriers.
|
JAMA
|
2008
|
3.30
|
|
3
|
A road map for efficient and reliable human genome epidemiology.
|
Nat Genet
|
2006
|
3.21
|
|
4
|
Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases.
|
Am J Epidemiol
|
2009
|
2.15
|
|
5
|
Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.
|
J Clin Oncol
|
2010
|
1.85
|
|
6
|
Background parenchymal enhancement at breast MR imaging and breast cancer risk.
|
Radiology
|
2011
|
1.74
|
|
7
|
The emergence of networks in human genome epidemiology: challenges and opportunities.
|
Epidemiology
|
2007
|
1.61
|
|
8
|
Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study.
|
Int J Radiat Oncol Biol Phys
|
2008
|
1.58
|
|
9
|
Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger.
|
Breast Cancer Res Treat
|
2011
|
1.47
|
|
10
|
GLIOGENE an International Consortium to Understand Familial Glioma.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
1.42
|
|
11
|
Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.
|
Hum Mutat
|
2010
|
1.40
|
|
12
|
The Glioma International Case-Control Study: A Report From the Genetic Epidemiology of Glioma International Consortium.
|
Am J Epidemiol
|
2015
|
1.27
|
|
13
|
Rare germline mutations in PALB2 and breast cancer risk: a population-based study.
|
Hum Mutat
|
2012
|
1.26
|
|
14
|
Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study.
|
J Natl Cancer Inst
|
2007
|
1.18
|
|
15
|
Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study.
|
J Clin Oncol
|
2012
|
1.13
|
|
16
|
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.
|
Breast Cancer Res Treat
|
2010
|
1.11
|
|
17
|
A review of cancer in U.S. Hispanic populations.
|
Cancer Prev Res (Phila)
|
2012
|
1.11
|
|
18
|
Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium.
|
Cancer Res
|
2011
|
1.05
|
|
19
|
Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.05
|
|
20
|
Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling.
|
Genet Epidemiol
|
2011
|
1.04
|
|
21
|
Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.
|
Cancer Res
|
2008
|
1.00
|
|
22
|
Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study.
|
Am J Epidemiol
|
2009
|
1.00
|
|
23
|
Reproductive history and risk of second primary breast cancer: the WECARE study.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.99
|
|
24
|
Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.
|
Hum Mutat
|
2011
|
0.98
|
|
25
|
Incorporating prior biologic information for high-dimensional rare variant association studies.
|
Hum Hered
|
2013
|
0.98
|
|
26
|
Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
0.96
|
|
27
|
ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.95
|
|
28
|
Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium.
|
Eur J Cancer
|
2013
|
0.94
|
|
29
|
Body mass index and risk of second primary breast cancer: the WECARE Study.
|
Breast Cancer Res Treat
|
2011
|
0.93
|
|
30
|
Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study.
|
Breast Cancer Res
|
2011
|
0.92
|
|
31
|
On the proposed association of the ATM variants 5557G>A and IVS38-8T>C and bilateral breast cancer.
|
Int J Cancer
|
2006
|
0.90
|
|
32
|
Statistical methods for analysis of radiation effects with tumor and dose location-specific information with application to the WECARE study of asynchronous contralateral breast cancer.
|
Biometrics
|
2008
|
0.89
|
|
33
|
A conceptual and methodological framework for investigating etiologic heterogeneity.
|
Stat Med
|
2013
|
0.86
|
|
34
|
Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status.
|
Breast Cancer Res Treat
|
2010
|
0.83
|
|
35
|
A variable age of onset segregation model for linkage analysis, with correction for ascertainment, applied to glioma.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.83
|
|
36
|
Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study.
|
Cancer Causes Control
|
2010
|
0.82
|
|
37
|
Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma.
|
Hum Genet
|
2012
|
0.81
|
|
38
|
Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.81
|
|
39
|
Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group.
|
J Clin Oncol
|
2008
|
0.80
|
|
40
|
Variants in tamoxifen metabolizing genes: a case-control study of contralateral breast cancer risk in the WECARE study.
|
Int J Mol Epidemiol Genet
|
2013
|
0.80
|
|
41
|
Variation in genes related to obesity, weight, and weight change and risk of contralateral breast cancer in the WECARE Study population.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.79
|
|
42
|
Survey of familial glioma and role of germline p16INK4A/p14ARF and p53 mutation.
|
Fam Cancer
|
2010
|
0.78
|
|
43
|
Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study.
|
Breast Cancer Res Treat
|
2009
|
0.77
|
|
44
|
Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study.
|
Cancer Causes Control
|
2013
|
0.75
|